Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Dec. 17, 2013 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 17, 2013

Aethersys, Amgen, Amneal, Aquinox, ArGEN-X, Asmacure, Boehringer Ingelheim, Hanmi, Ipsen, RedHill Biopharma, Sucampo, Takeda

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
ArGEN-X hits dose escalation goals . . . read more

Phase II
Aquinox begins COPD trial . . . read more

Asmacure advances lead lung compound . . . read more

Phase III
Amgen MAb reduces LDL-C . . . read more

BI drug hits endpoint in VTE trial . . . read more

Ipsen’s Dysport posts positive results in spasticity trial . . . read more

RedHill begins dosing gastritis trial . . . read more

Sucampo, Takeda begin constipation trials . . . read more

Filings
Aethersys gets Orphan status in EU for stem cell GvHD therapy . . . read more

Launches
Amneal releases Nexium alternative . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics